Delivery Order SPE2DB24D1034-SPE2DB25FWEQ4
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $2,800.18 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,147,140 units of Propranolol ER 160 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,935.69 firm fixed-price delivery order is for the supply of 4,567,021,550 units of the medication Propranolol ER 80 mg capsules. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for 4,563,982,023 units of Propranolol ER 160 mg capsules in 100-count bottles, with a ceiling value of $2,529.33. The order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, to provide pharmaceutical products and medical supplies to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Propranolol ER 160 mg capsules. The contract is a firm-fixed-price delivery order with a ceiling value of $2,670.68 and a period of performance through November 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a $6,914.99 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,567,906,451 units of Propranolol ER 80 mg capsules. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. This delivery order is part of a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,039.20 firm fixed-price contract is for the delivery of 4,568,239,286 units of the medication propranolol ER 60 mg capsule. The contract has a performance period through May 15, 2025 and is not set-aside. Amerisourcebergen Drug Corp is the prime contractor and there are no subcontractors mentioned. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,830,226 units of the medication PROPRANOLOL ER 160 MG CAPSULE 100S. The $1,798.18 contract has a completion date of March 4, 2024 and was awarded on March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a larger indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,586.09 delivery order contract covers the supply of 100-count capsules of the drug Propranolol ER 160 mg. The contract has an ultimate completion date of June 14, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,351,716 units of Propranolol ER 120 mg capsules, with a ceiling value of $1,230.66. The contract has a period of performance through February 25, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,889.82 firm fixed-price delivery order is for the supply of 100 capsules of Propranolol ER 80 mg, a cardiovascular medication. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWEQ4Delivery Order
The Defense Logistics Agency (DLA) awarded a $1,469.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Propranolol ER 160 mg capsules (100-count units). The contract is non-set-aside and represents a competitively awarded delivery order with an ultimate completion date of July 24, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive federal contracting portfolio with DLA and other government healthcare systems, demonstrating established capability to fulfill federal medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/23/25 |